Study: Black people may respond differently to common multiple sclerosis therapy than white people
Most young people eager for COVID-19 vaccine, poll shows
14 April 2021Psilocybin performs at least as well as leading antidepressant in small study
14 April 2021Study: Black people may respond differently to common multiple sclerosis therapy than white people
A preliminary study suggests that Black people who have autoimmune neurologic diseases, multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD), may respond differently than white people to a common therapy meant to modulate the immune system. The research, released today, April 14, 2021, will be presented at the American Academy of Neurology’s 73rd Annual Meeting being held virtually April 17 to 22, 2021.
